Who is sponsoring NCT03592225?

NCT03592225 is sponsored by International Agency for Research on Cancer.

What drugs are being tested in NCT03592225?

Interventions in NCT03592225: Educational workshop.

What condition does NCT03592225 study?

NCT03592225 studies Human Papillomavirus Vaccination.

Is NCT03592225 still recruiting?

NCT03592225 is currently status unknown. Last updated 26 May 2022.

Last reviewed 2022-05-26 · How we verify

NCT03592225: PAPRICA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Can an Educational Intervention Targeting General Practitioners Increase HPV Vaccination Coverage in AuRA_Lyon (France)

Status unknown NA Last updated 26 May 2022

What this trial tests

NA trial testing Educational workshop in Human Papillomavirus Vaccination in 300 participants. Status unknown.

Timeline

1 March 2016

Primary endpoint
30 March 2023

30 March 2023

Quick facts

Lead sponsor	International Agency for Research on Cancer
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	300
Start date	1 March 2016
Primary completion	30 March 2023
Estimated completion	30 March 2023
Sites	1 location across France

Drugs / interventions tested

Educational workshop

Conditions studied

Human Papillomavirus Vaccination — all drugs for Human Papillomavirus Vaccination →

Sponsor

International Agency for Research on Cancer

Who can join

Eligibility, any sex, with Human Papillomavirus Vaccination. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The PAPRICA implementation trial aims to test the efficacy of an educational intervention about HPV vaccination and targeting general practitioners in Lyon

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Human Papillomavirus Vaccination

Currently open trials in the same condition.

NCT06808776 — Stories to Prevent (StoP) HPV Cancers · NA · recruiting
NCT06161831 — HPV Vaccine Reminders - SEARCH II Study · NA · active not recruiting

Other International Agency for Research on Cancer trials

Trials by the same sponsor.

NCT07256912 — A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared t · Phase 4 · not yet recruiting
NCT07193030 — Peer-Led Intervention To Reduce Alcohol Binge Drinking Among University Students In Romania · NA · not yet recruiting
NCT05286034 — Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme · NA · recruiting
NCT06749847 — HPV Self-sampling in the General Population · NA · recruiting
NCT07407153 — Triaging of Women Detected With a Breast Lump on Clinical Breast Examination Using Portable Ultrasound Device · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03592225 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by International Agency for Research on Cancer
Last refreshed: 26 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03592225.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing